The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest surviv...
Autors principals: | Chow, J, Leong, KMW, Shun-Shin, M, Jones, S, Guttmann, OP, Mohiddin, SA, Lambiase, P, Elliott, PM, Ormerod, JOM, Koa-Wing, M, Lefroy, D, Lim, PB, Linton, NWF, Ng, FS, Qureshi, NA, Whinnett, ZI, Peters, NS, Francis, DP, Varnava, AM, Kanagaratnam, P |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Frontiers Media
2024
|
Ítems similars
-
The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
per: Ji-Jian Chow, et al.
Publicat: (2024-08-01) -
Ventricular Conduction Stability Noninvasively Identifies an Arrhythmic Substrate in Survivors of Idiopathic Ventricular Fibrillation
per: Ji‐Jian Chow, et al.
Publicat: (2023-04-01) -
Pseudo-arrhythmic ECG artifact
per: Satyajeet Singh, et al.
Publicat: (2012-01-01) -
Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
per: Lyon, A, et al.
Publicat: (2018) -
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: Coleman, JA, et al.
Publicat: (2024)